These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 6426834

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transfusion support for haemophiliacs.
    Allain JP.
    Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Viral safety of plasma-derived factor VIII and IX concentrates.
    Ludlam CA.
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S19-23. PubMed ID: 9351532
    [Abstract] [Full Text] [Related]

  • 7. [Revision consensus hemophilia: treatment and responsibility. Nederlandse Vereniging van Hemophilia Patients].
    Briët E, Mauser-Bunschoten EP.
    Ned Tijdschr Geneeskd; 1997 Dec 27; 141(52):2566-71. PubMed ID: 9555158
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Use of blood products and factor concentrates for coagulation therapy.
    Fritsma MG.
    Clin Lab Sci; 2003 Dec 27; 16(2):115-9. PubMed ID: 12757192
    [Abstract] [Full Text] [Related]

  • 11. The challenge arising from the cost of haemophilia care: an audit of haemophilia treatment at Auckland Hospital.
    Harper P, Brasser M, Moore L, Teague L, Pitcher L, Ockelford P.
    N Z Med J; 2003 Aug 22; 116(1180):U561. PubMed ID: 14581983
    [Abstract] [Full Text] [Related]

  • 12. Immunopurified clotting factor concentrates.
    Mariani G, Di Nucci GD, Arcieri P.
    Nouv Rev Fr Hematol (1978); 1994 Aug 22; 36 Suppl 1():S61-5. PubMed ID: 8177718
    [Abstract] [Full Text] [Related]

  • 13. New alternatives and strategies in the treatment of inhibitors.
    Hoyer LW.
    Prog Clin Biol Res; 1984 Aug 22; 150():367-72. PubMed ID: 6431440
    [Abstract] [Full Text] [Related]

  • 14. [Therapy-induced hepatitis risk in hemophilia patients].
    Schiller WG, Renger FG.
    Z Arztl Fortbild (Jena); 1983 Aug 22; 77(19):807-10. PubMed ID: 6417919
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Recombinant blood clotting proteins for hemophilia therapy.
    Limentani SA, Roth DA, Furie BC, Furie B.
    Semin Thromb Hemost; 1993 Aug 22; 19(1):62-72. PubMed ID: 8456325
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasma exchange donation of cryoprecipitate after DDAVP stimulation: an alternative source of factor VIII.
    McLeod BC, Scott JP.
    Prog Clin Biol Res; 1990 Aug 22; 324():189-98. PubMed ID: 2106687
    [Abstract] [Full Text] [Related]

  • 19. [Inhibitor hemophilia in oral surgery].
    Schulz S.
    Zahn Mund Kieferheilkd Zentralbl; 1984 Aug 22; 72(8):824-8. PubMed ID: 6240865
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.